Read more

July 14, 2020
1 min read
Save

Top in ID: AIDS 2020 highlights, US withdrawal from WHO

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Details of the first case of long-term HIV remission that did not require a bone marrow transplant were presented during the virtual International AIDS 2020 Conference. It was the top story in infectious disease last week.

During another presentation, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, warned physicians about the potential for airborne spread of COVID-19.

Trump announced in a Rose Garden press event that the U.S. would sever ties with WHO. Credit: White House/Joyce N. Boghosian
Experts have responded to President Donald J. Trump's announcement on his intention to formally withdraw the United States from WHO, highlighting the dangers of the decision. Credit: White House/Joyce N. Boghosian.

Read these and more top stories in infectious disease below:

Man achieves long-term HIV remission without bone marrow transplant

Researchers reported the first case of long-term HIV remission without the need for a bone marrow transplant. Read more.

Fauci: COVID-19 was ID physicians’ ‘worst nightmare,’ warns of potential airborne spread

During an International AIDS 2020 press conference, Fauci said that, before the COVID-19 pandemic, the idea of a highly contagious respiratory illness was many infectious disease physicians’ “worst nightmare.” Read more.

Experts react to ‘ruinous’ decision to withdraw US from WHO

Last week, President Donald J. Trump announced his intention to formally withdraw the United States from WHO. Read more.

COVID-19 knocks HIV goals ‘completely off track’

COVID-19 will set back the goal to end AIDS by 2030, stalling an already off-track goal even further, according to a presentation from the opening session of the AIDS 2020 virtual meeting. Read more.

Trial ‘definitively’ shows superiority of long-acting injectable PrEP

A PrEP regimen containing long-acting injectable cabotegravir (ViiV Healthcare) provided superior protection against HIV infection compared with daily oral PrEP, updated study findings confirmed. Read more.